[
  {
    "ts": null,
    "headline": "PLSE Shares Rise on First-in-Human Data for Thyroid Nodule Treatment",
    "summary": "Pulse Biosciences shares rise on first-in-human study showing its nsPFA tech cuts thyroid nodule size with strong safety and efficacy.",
    "url": "https://finnhub.io/api/news?id=f3d3b8bf83a9a45253f3ed0a89a0d86fbcc7849ddab77a98db6494cceeea4031",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756311900,
      "headline": "PLSE Shares Rise on First-in-Human Data for Thyroid Nodule Treatment",
      "id": 136539693,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Pulse Biosciences shares rise on first-in-human study showing its nsPFA tech cuts thyroid nodule size with strong safety and efficacy.",
      "url": "https://finnhub.io/api/news?id=f3d3b8bf83a9a45253f3ed0a89a0d86fbcc7849ddab77a98db6494cceeea4031"
    }
  },
  {
    "ts": null,
    "headline": "What's Driving Abbott's Gross Margin Growth Amid Macro Issues",
    "summary": "ABT's gross margin hits 56.4% in Q2, fueled by Medical Devices growth, Nutrition strength, FX tailwinds and cost discipline.",
    "url": "https://finnhub.io/api/news?id=9ffb6494a9ce693a6b1c40fc0cfe49c4fa5bdd4ca41481e9d8ec18bdae6a3487",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756298400,
      "headline": "What's Driving Abbott's Gross Margin Growth Amid Macro Issues",
      "id": 136539629,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "ABT's gross margin hits 56.4% in Q2, fueled by Medical Devices growth, Nutrition strength, FX tailwinds and cost discipline.",
      "url": "https://finnhub.io/api/news?id=9ffb6494a9ce693a6b1c40fc0cfe49c4fa5bdd4ca41481e9d8ec18bdae6a3487"
    }
  },
  {
    "ts": null,
    "headline": "Should You Add IDEXX Stock to Your Portfolio Right Now?",
    "summary": "IDXX gains from strong CAG Diagnostics growth and rising cloud software demand, but debt levels remain a concern for investors.",
    "url": "https://finnhub.io/api/news?id=62b398e832242af95824a95d3d670648074d3b43f1e03b3973007c49fe46d654",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756297860,
      "headline": "Should You Add IDEXX Stock to Your Portfolio Right Now?",
      "id": 136536604,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "IDXX gains from strong CAG Diagnostics growth and rising cloud software demand, but debt levels remain a concern for investors.",
      "url": "https://finnhub.io/api/news?id=62b398e832242af95824a95d3d670648074d3b43f1e03b3973007c49fe46d654"
    }
  },
  {
    "ts": null,
    "headline": "Here's Why You Should Retain CONMED Stock in Your Portfolio for Now",
    "summary": "CNMD's growth drivers - AirSeal, Buffalo Filter, BioBrace, and Foot & Ankle - are offsetting tariffs and supply risks, making the stock worth retaining.",
    "url": "https://finnhub.io/api/news?id=a6bbf3909e5378ff6728d942252377fe173669aea87eb6e386304159f982f5a7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756297740,
      "headline": "Here's Why You Should Retain CONMED Stock in Your Portfolio for Now",
      "id": 136536605,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "CNMD's growth drivers - AirSeal, Buffalo Filter, BioBrace, and Foot & Ankle - are offsetting tariffs and supply risks, making the stock worth retaining.",
      "url": "https://finnhub.io/api/news?id=a6bbf3909e5378ff6728d942252377fe173669aea87eb6e386304159f982f5a7"
    }
  },
  {
    "ts": null,
    "headline": "REALIZE Demo Day to Spotlight Health Tech Startups with Expert Insights and Investor Feedback",
    "summary": "University Lab Partners (ULP) will host the REALIZE Demo Day on Wednesday, September 17, 2025, from 5:00–8:00 PM PT at UCI Beall Applied Innovation at the Cove. The event marks the capstone of the REALIZE Accelerator program, showcasing live pitch presentations from 11 pioneering med tech startups developing breakthroughs in medical devices, diagnostics, and digital health.",
    "url": "https://finnhub.io/api/news?id=68e23c8891967c824e4cc6044d624634cbc930935a7f68070209c315ca8b1d9b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756281600,
      "headline": "REALIZE Demo Day to Spotlight Health Tech Startups with Expert Insights and Investor Feedback",
      "id": 136536606,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "University Lab Partners (ULP) will host the REALIZE Demo Day on Wednesday, September 17, 2025, from 5:00–8:00 PM PT at UCI Beall Applied Innovation at the Cove. The event marks the capstone of the REALIZE Accelerator program, showcasing live pitch presentations from 11 pioneering med tech startups developing breakthroughs in medical devices, diagnostics, and digital health.",
      "url": "https://finnhub.io/api/news?id=68e23c8891967c824e4cc6044d624634cbc930935a7f68070209c315ca8b1d9b"
    }
  }
]